Kallen Marlot C, Prins Jan M
Department of Internal Medicine, Division of Infectious Diseases, Academic Medical Centre, University of Amsterdam, the Netherlands.
Infect Dis Rep. 2017 Mar 30;9(1):6821. doi: 10.4081/idr.2017.6821.
Many quality indicators for appropriate antibiotic use have been developed. We aimed to make a systematic inventory, including the development methodology and validation procedures, of currently available quality indicators (QIs) for appropriate antibiotic use in hospitalized adult patients. We performed a literature search in the Pubmed interface. From the included articles we abstracted i) the indicators developed ii) the type of infection the QIs applied to iii) study design used for the development of the QIs iv) relation of the QIs to outcome measures v) whether the QIs were validated and vi) the characteristics of the validation cohort. Fourteen studies were included, in which 200 QIs were developed The most frequently mentioned indicators concerned empirical antibiotic therapy according to the guideline (71% of studies), followed by switch from IV to oral therapy (64% of studies), followed by drawing at least two sets of blood cultures and change to pathogen-directed therapy based on culture results (57% of studies). Most QIs were specifically developed for lower respiratory tract infection, urinary tract infection or sepsis. A RAND-modified Delphi procedure was used in the majority of studies (57%). Six studies took outcome measures into consideration during the procedure. Five out of fourteen studies (36%) tested the clinimetric properties of the QIs and 65% of the tested QIs were considered valid. Many studies report the development of quality indicators for appropriate antibiotic use in hospitalized adult patients. However, only a small number of studies validated the developed QIs. Future validation of QIs is needed if we want to implement them in daily practice.
目前已制定了许多关于合理使用抗生素的质量指标。我们旨在对目前可用于住院成年患者合理使用抗生素的质量指标(QIs)进行系统梳理,包括其开发方法和验证程序。我们在PubMed界面进行了文献检索。从纳入的文章中,我们提取了以下信息:i)所制定的指标;ii)质量指标所适用的感染类型;iii)用于制定质量指标的研究设计;iv)质量指标与结局指标的关系;v)质量指标是否经过验证;vi)验证队列的特征。共纳入14项研究,其中制定了200项质量指标。提及频率最高的指标涉及根据指南进行经验性抗生素治疗(71%的研究),其次是从静脉治疗转换为口服治疗(64%的研究),然后是采集至少两套血培养标本并根据培养结果改为针对性病原治疗(57%的研究)。大多数质量指标是专门针对下呼吸道感染、尿路感染或脓毒症制定的。大多数研究(57%)采用了兰德公司改良的德尔菲法。六项研究在制定过程中考虑了结局指标。14项研究中有五项(36%)测试了质量指标的临床测量特性,其中65%的经测试质量指标被认为有效。许多研究报告了住院成年患者合理使用抗生素质量指标的制定情况。然而,只有少数研究对所制定的质量指标进行了验证。如果我们想在日常实践中应用这些质量指标,未来还需要进行验证。